Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC.

J Am Soc Nephrol. 2016 Nov 7. pii: ASN.2016060640. [Epub ahead of print]

PMID:
27821627
2.

A Proposal for a Serology-Based Approach to Membranous Nephropathy.

De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC.

J Am Soc Nephrol. 2016 Oct 24. pii: ASN.2016070776. [Epub ahead of print]

PMID:
27777266
3.

In Reply to 'C4 Deposition in Glomerular Disease'.

Sethi S, Fervenza FC.

Am J Kidney Dis. 2016 Nov;68(5):817. doi: 10.1053/j.ajkd.2016.08.011. No abstract available.

PMID:
27772631
4.

Outcomes of patients with renal monoclonal immunoglobulin deposition disease.

Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N.

Am J Hematol. 2016 Nov;91(11):1123-1128. doi: 10.1002/ajh.24528.

PMID:
27501122
5.

Characterization of C3 in C3 glomerulopathy.

Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJ.

Nephrol Dial Transplant. 2016 Aug 8. pii: gfw290. [Epub ahead of print]

PMID:
27507892
6.

Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group.

Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thomé SD, Hook CC; Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group..

Mayo Clin Proc. 2016 Sep;91(9):1189-211. doi: 10.1016/j.mayocp.2016.05.015.

PMID:
27497856
7.

ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U.

Nat Rev Rheumatol. 2016 Oct;12(10):570-9. doi: 10.1038/nrrheum.2016.123. Review.

PMID:
27464484
8.

The association of serum calprotectin (S100A8/S100A9) levels with disease relapses in PR3-ANCA-associated vasculitis.

Pepper RJ, Draibe JB, Caplin B, Fervenza FC, Hoffman GS, Kallenberg CG, Langford CA, Monach PA, Seo P, Spiera R, St Clair EW, Tchao NK, Stone JH, Specks U, Merkel PA, Salama AD; RAVE-ITN Research Group..

Arthritis Rheumatol. 2016 Jul 18. doi: 10.1002/art.39814. [Epub ahead of print]

PMID:
27428710
9.

Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.

Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH.

Arthritis Rheumatol. 2016 Dec;68(12):2945-2952. doi: 10.1002/art.39812.

PMID:
27428559
10.

Recurrent Light Chain Proximal Tubulopathy in a Kidney Allograft.

Angioi A, Amer H, Fervenza FC, Sethi S.

Am J Kidney Dis. 2016 Sep;68(3):483-7. doi: 10.1053/j.ajkd.2016.04.021.

PMID:
27321964
11.

C4d as a marker for masked immune deposits.

Sethi S, Hernandez LH, Alexander MP, Fervenza FC.

Kidney Int. 2016 Jul;90(1):223-4. doi: 10.1016/j.kint.2016.02.041. No abstract available.

PMID:
27312449
12.

Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.

Dasari S, Amin MS, Kurtin PJ, Vrana JA, Theis JD, Grogg KL, Alexander MP, Nasr SH, Fervenza FC, Leung N, Sethi S.

Kidney Int. 2016 Sep;90(3):658-64. doi: 10.1016/j.kint.2016.04.003.

PMID:
27262366
13.

Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy.

Kattah AG, Alexander MP, Angioi A, De Vriese AS, Sethi S, Cosio FG, Lorenz EC, Cornell LD, Fervenza FC.

Am J Transplant. 2016 Oct;16(10):2964-72. doi: 10.1111/ajt.13806.

PMID:
27017874
14.

Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.

Dalvin LA, Fervenza FC, Sethi S, Pulido JS.

Ophthalmology. 2016 Jul;123(7):1588-94. doi: 10.1016/j.ophtha.2016.02.018.

PMID:
26996341
15.

The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.

Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, Sethi S, Leung N, Fervenza FC, Cornell LD.

Kidney Int. 2016 Apr;89(4):897-908. doi: 10.1016/j.kint.2016.02.001.

PMID:
26994577
16.

C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition.

Sethi S, Quint PS, O'Seaghdha CM, Fervenza FC, Bijol V, Dorman A, Dasari S, Smith RJ, Kurtin PJ, Rennke HG.

Am J Kidney Dis. 2016 Jun;67(6):949-53. doi: 10.1053/j.ajkd.2016.01.012.

PMID:
26896898
17.

Diagnosis of complement alternative pathway disorders.

Angioi A, Fervenza FC, Sethi S, Zhang Y, Smith RJ, Murray D, Van Praet J, Pani A, De Vriese AS.

Kidney Int. 2016 Feb;89(2):278-88. doi: 10.1016/j.kint.2015.12.003.

PMID:
26806831
18.

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis.

Cheungpasitporn W, Zacharek CC, Fervenza FC, Cornell LD, Sethi S, Herrera Hernandez LP, Nasr SH, Alexander MP.

Clin Kidney J. 2016 Feb;9(1):97-101. doi: 10.1093/ckj/sfv126.

19.

Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease.

Tran CL, Sethi S, Murray D, Cramer CH, Sas DJ, Willrich M, Smith RJ, Fervenza FC.

Pediatr Nephrol. 2016 Apr;31(4):683-7. doi: 10.1007/s00467-015-3306-0.

PMID:
26759144
20.

Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.

Sethi S, Fervenza FC, Rajkumar SV.

Curr Opin Nephrol Hypertens. 2016 Mar;25(2):127-37. doi: 10.1097/MNH.0000000000000201. Review.

PMID:
26735145
Items per page

Supplemental Content

Loading ...
Support Center